180 related articles for article (PubMed ID: 15231658)
21. Caspase-dependent cell death mediates potent cytotoxicity of sulfide derivatives of 9-anilinoacridine.
Park SK; Kang H; Kwon CH
Anticancer Drugs; 2008 Apr; 19(4):381-9. PubMed ID: 18454048
[TBL] [Abstract][Full Text] [Related]
22. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
[TBL] [Abstract][Full Text] [Related]
23. Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester.
Tentori L; Balduzzi A; Portarena I; Levati L; Vernole P; Gold B; Bonmassar E; Graziani G
Cell Death Differ; 2001 Aug; 8(8):817-28. PubMed ID: 11526435
[TBL] [Abstract][Full Text] [Related]
24. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
Markovits J; Pommier Y; Kerrigan D; Covey JM; Tilchen EJ; Kohn KW
Cancer Res; 1987 Apr; 47(8):2050-5. PubMed ID: 3030540
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
27. Apoptotic and genotoxic effects of a methyl sulfonate ester that selectively generates N3-methyladenine and poly(ADP-ribose) polymerase inhibitors in normal peripheral blood lymphocytes.
Tentori L; Portarena I; Vernole P; Gold B; Graziani G
Cancer Chemother Pharmacol; 2002 Mar; 49(3):217-24. PubMed ID: 11935214
[TBL] [Abstract][Full Text] [Related]
28. G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford B; Beljin M; Stark GR; Taylor WR
Cancer Res; 2003 Jul; 63(14):4074-81. PubMed ID: 12874009
[TBL] [Abstract][Full Text] [Related]
29. PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells.
Węsierska-Gądek J; Zulehner N; Ferk F; Składanowski A; Komina O; Maurer M
Biochem Pharmacol; 2012 Nov; 84(10):1318-31. PubMed ID: 22906755
[TBL] [Abstract][Full Text] [Related]
30. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
[TBL] [Abstract][Full Text] [Related]
31. Imidazoquinolinone, imidazopyridine, and isoquinolindione derivatives as novel and potent inhibitors of the poly(ADP-ribose) polymerase (PARP): a comparison with standard PARP inhibitors.
Eltze T; Boer R; Wagner T; Weinbrenner S; McDonald MC; Thiemermann C; Bürkle A; Klein T
Mol Pharmacol; 2008 Dec; 74(6):1587-98. PubMed ID: 18809672
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor).
Chen Y; Su YH; Wang CH; Wu JM; Chen JC; Tseng SH
Anticancer Res; 2005; 25(6B):4203-8. PubMed ID: 16309217
[TBL] [Abstract][Full Text] [Related]
33. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.
Maurich T; Iorio M; Chimenti D; Turchi G
Chem Biol Interact; 2006 Feb; 159(2):104-16. PubMed ID: 16271357
[TBL] [Abstract][Full Text] [Related]
34. [Induction of G2 /M phase arrest and apoptosis of MCF-7 cells by novel benzofuran lignan via suppressing cell cycle proteins].
Yang H; Cai YC; Pang JY; Li YQ; Zeng ZL; Xu ZL; Xian LJ
Yao Xue Xue Bao; 2008 Feb; 43(2):138-44. PubMed ID: 18507339
[TBL] [Abstract][Full Text] [Related]
35. p63 involvement in poly(ADP-ribose) polymerase 1 signaling of topoisomerase I-dependent DNA damage in carcinoma cells.
Montariello D; Troiano A; Malanga M; Calabrò V; Quesada P
Biochem Pharmacol; 2013 Apr; 85(7):999-1006. PubMed ID: 23376119
[TBL] [Abstract][Full Text] [Related]
36. Quantitative correlation between cellular proliferation and nuclear poly (ADP-ribose) polymerase (PARP-1).
Kun E; Kirsten E; Bauer PI; Ordahl CP
Int J Mol Med; 2006 Feb; 17(2):293-300. PubMed ID: 16391829
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
38. Effects of poly(ADP-ribose) polymerase inhibition on cell death and chromosome damage induced by VP16 and bleomycin.
D'Agnano I; Antonelli A; Bucci B; Marcucci L; Petrinelli P; Ambra R; Zupi G; Elli R
Environ Mol Mutagen; 1998; 32(1):56-63. PubMed ID: 9707099
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation.
Finlay GJ; Holdaway KM; Baguley BC
Oncol Res; 1994; 6(1):33-7. PubMed ID: 7919550
[TBL] [Abstract][Full Text] [Related]
40. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]